Nucleic acid-based cross-linking assay for detection and quantification of hepatitis B virus DNA

Journal of Clinical Microbiology

Volumn 37, Issue 1, 1999, Pages 161-164

  Lai, Vicky C H ^b   Guan, Richard ^b   Wood, Michael L ^a   Lo, Su Kong ^b   Yuen, Man Fung ^b   Lai, Ching Lung ^b  

^a NAXCOR   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ACCURACY; ARTICLE; CONTROLLED STUDY; DNA CROSS LINKING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; NONHUMAN; NUCLEIC ACID HYBRIDIZATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SERUM; VIRUS DETECTION;

CHIRON; DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0032934245     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.1.161-164.1999     Document Type: Article

References (13)

1. Aach, R. A. 1988. The treatment of chronic type B viral hepatitis. Ann. Intern. Med. 109:89-90.
2. Alter, M. J., and E. E. Mast. 1994. The epidemiology of viral hepatitis in the United States. Gastroenterol. Clin. N. Am. 23:437-455.
3. Butterworth, L. A., S. L. Prior, P. J. Buda, J. L. Faoagali, and W. G. E. Cooksley. 1996. Comparison of four methods for quantitative measurement of hepatitis B viral DNA. J. Hepatol. 24:686-691.
4. Carman, W. F., M. R. Jacyna, S. Hadziyannis, P. Karayiannis, M. J. McGarvey, A. Makris, and H. C. Thomas. 1989. Mutation preventing formation of e antigen in patients with chronic HBV infection. Lancet ii:588-591.
5. Gerlich, W. H., K. H. Heermann, R. Thomssen, and the Eurohep Group. 1995. Quantitative assays for hepatitis B virus DNA: standardization and quality control. Viral Hepatitis Rev. 1:53-57.
6. Gitlin, N. 1997. Hepatitis B: diagnosis, prevention, and treatment. Clin. Chem. 43:1500-1506.
7. Hoofnagle, J. H. 1990. α-Interferon treatment therapy of chronic hepatitis B. Current status and recommendations. J. Hepatol. 11:S100-S107.
8. Janssen, H. L. A., Y. A. M. Schoenmaker-Weber, H. Kruining, S. W. Schalm, and R. A. Heijtink. 1993. Quantitative assessment of hepatitis B virus DNA in chronic hepatitis B: comparison of two solution hybridization assays. J. Med. Virol. 40:307-312.
9. Pawlotsky, J.-M., A. Bastie, I. Lonjon, J. Rémiré. F. Darthuy, C.-J. Soussy, and D. Dhumeaux. 1997. What technique should be used for routine detection and quantification of HBV DNA in clinical samples? J. Virol. Methods 65:245-253.
10. Quint, W. G. V., R. A. Heijtink, J. Schirm, W. H. Gerlich, and H. G. M. Niesters. 1995. Reliability of methods for hepatitis B virus DNA detection. J. Clin. Microbiol. 33:225-228.
11. Wood, M., D. Albagli, P. Cheng, B. Huan, and R. Van Atta. 1996. Nucleic acid crosslinking probes for DNA/RNA diagnostics. Clin. Chem. 42:S196.
12. Zaaijer, H. L., F. Ter-Borg, H. T. M. Cuypers, M. C. A. H. Hermus, and P. N. Lelie. 1994. Comparison of methods for detection of hepatitis B virus DNA. J. Clin. Microbiol. 32:2088-2091.
13. Zehnder, J., R. Van Atta, C. Jones, H. Sussman, and M. Wood. 1997. Crosslinking hybridization assay for direct detection of the factor V Leiden mutation. Clin. Chem. 43:1703-1708.